Nasdaq-listed Alvotech, an Iceland-headquartered global biotech company specialising in biosimilars, has placed US$108m 6.875% senior unsecured convertible bonds due 2030. The initial conversion price is fixed at US$5.9224 per share, representing a conversion premium of 25% over US$4.7379 per share.
“This financing ensures we remain well positioned to advance our...
The UK's special educational needs (SEN) sector is at a critical juncture. The pressures are both structural and acute.
Rising diagnoses of autism, ADHD and other conditions, accelerated by the pandemic's impact on child development, have driven rapid growth in demand. Numbers of children with Education, Health and Care Plans (EHCP) increased by 10.8% in the year to January 2025, and the total number has doubled since 2016. Meanwhile, mainstream schools are struggling to cope with the most complex cases, and the state sector has scaled back provision, leaving independent...
